Back to search

Article

Protocol for a cross-sectional study: Effects of a Multiple Sclerosis Relapse Therapy with Methylprednisolone on Offspring Neurocognitive Development and Behaviour (MS-Children)

2021-11-16

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Multiple Sclerosis (MS) is the most common neuroimmunological disease in women of childbearing age. Current MS therapy consists of immunomodulatory relapse prevention with disease-modifying therapies (DMTs) and acute relapse therapy with the synthetic glucocorticoid (GC) methylprednisolone (MP). As most DMTs are not approved for use during pregnancy, treatment is usually dis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d65da9cc-23a6-503b-8eac-2d2c300bc244
DOI
10.1101/2021.11.15.21266211
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Protocol for a cross-sectional study: Effects of a Multiple Sclerosis Relapse Therapy with Methylprednisolone on Offspring Neurocognitive Development and Behaviour (MS-Children)DOI 10.1101/2021.11.15.21266211
Select a neighboring publication to make it the new centre.